TEAM{理監事團隊}

學歷

• 臺北醫學大學醫學士
• 陽明大學臨床醫學研究所博士

經歷

1. 台北榮民總醫院兒童醫學部住院醫師
2. 台北榮民總醫院兒童神經科臨床研究員
3. 台北榮民總醫院兒童醫學部 兒童神經癲癇科 主任
4. 教育部定陽明大學醫學系 助理教授

專長領域

1. 兒童神經疾病
2. 發展評估與發展遲緩
3. 兒童癲癇
4. 兒童重症醫學
5. 行為問題
6. 頭痛
7. 動作障礙
8. 睡眠問題
9. 神經肌肉疾病
10. 神經免疫疾病

專業著作

• Weng WC, Chan SHS, Gomez R, Wang F, Chou HW, Lim J, et al. Optimizing DMD management in Asia: Current challenges and future directions. J Neuromuscul Dis. 2025;12(1):22143602241297846.
• Lu YH, Lin WS, Niu DM, Hsu TR. Reviews of spinal muscular atrophy in Taiwan. Tungs' Medical Journal. 2024;18:55-60.
• Lin WS, Hsu TR. Revisiting the roles of glucose transporters in skeletal muscle physiology: is GLUT10 a novel player? Biochemical and biophysical research communications. 2024;696:149494.
• Wang CY, Hsu TR, Chang KP. Clinical manifestations of psychogenic non-epileptic seizures in children: Experiences from a single center. Pediatr Neonatol. 2023;64(2):201-7.
• Lee WC, Chen HH, Yang TF, Lee TH, Hsu TR, Chen C, et al. Early Surgery for Ohtahara Syndrome Associated With Cortical Dysplasia. Pediatr Neurol. 2023;148:28-31.
• Chang FP, Hsu TR, Hung SC, Sung SH, Yu WC, Niu DM, et al. Cardiomyocyte Globotriaosylceramide Accumulation in Adult Male Patients with Fabry Disease and IVS4 + 919G>A GLA Mutation is Progressive with Age and Correlates with Left Ventricular Hypertrophy and Reduced Left Ventricular Ejection Fraction. medRxiv. 2023.
• Wu HW, Lin SC, Wu CL, Lee KL, Wu CH, Chen ST, et al. Indolent enhancing spinal lesions mimicking spinal metastasis in pediatric patients with malignant primary brain tumors. Scientific reports. 2022;12(1):1728.
• Lin WS, Lin SJ, Liao PY, Suresh D, Hsu TR, Wang PY. Role of Ketogenic Diets in Multiple Sclerosis and Related Animal Models: An Updated Review. Adv Nutr. 2022;13(5):2002-14.
• Lin JR, Cheng JF, Liu YT, Hsu TR, Lin KM, Chen C, et al. Novel lissencephaly-associated DCX variants in the C-terminal DCX domain affect microtubule binding and dynamics. Epilepsia. 2022;63(5):1253-65.
• Lin WS, Hsu TR. Hypothesis: Febrile infection-related epilepsy syndrome is a microglial NLRP3 inflammasome/IL-1 axis-driven autoinflammatory syndrome. Clin Transl Immunology. 2021;10(6):e1299.
• Huang CH, Hung PL, Fan PC, Lin KL, Hsu TR, Chou IJ, et al. Clinical spectrum and the comorbidities of Dravet syndrome in Taiwan and the possible molecular mechanisms. Scientific reports. 2021;11(1):20242.
• Wang WT, Sung SH, Liao JN, Hsu TR, Niu DM, Yu WC. Cardiac manifestations in patients with classical or cardiac subtype of Fabry disease. J Chin Med Assoc. 2020;83(9):825-9.
• Parini R, Pintos-Morell G, Hennermann JB, Hsu TR, Karabul N, Kalampoki V, et al. Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age. Drug design, development and therapy. 2020;14:2149-58.
• Lin WS, Lin SJ, Hsu TR. Cognitive Assessment and Rehabilitation for Pediatric-Onset Multiple Sclerosis: A Scoping Review. Children (Basel). 2020;7(10).
• Liang KH, Lu YH, Niu CW, Chang SK, Chen YR, Cheng CY, et al. The Fabry disease-causing mutation, GLA IVS4+919G>A, originated in Mainland China more than 800 years ago. Journal of human genetics. 2020;65(7):619-25.
• Hsu TR, Niu DM. Fabry disease: Review and experience during newborn screening. Trends in cardiovascular medicine. 2018;28(4):274-81.
• Hsu TR, CHang FP, Chu TH, Sung SH, Bizjajeva S, Yu WC, et al. Correlations between Endomyocardial Biopsies and Cardiac Manifestations in Taiwanese Patients with the Chinese Hotspot IVS4+919G>A Mutation:
• Data from the Fabry Outcome Survey. International journal of molecular sciences. 2017;18(1):119.
• Hsu TR, Hung SC, Chang FP, Yu WC, Sung SH, Hsu CL, et al. Later Onset Fabry Disease, Cardiac Damage Progress in Silence: Experience With a Highly Prevalent Mutation. J Am Coll Cardiol. 2016;68(23):2554-63.